Search for: "M.D." Results 41 - 60 of 6,619
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2024, 2:13 pm by Tom Mayo
" (Disclosure: One of the authors, Louise King, M.D., J.D., is a friend and former colleague.)The context for this question is not surprising:Two Texas court cases were filed in late 2023 requesting clarification of the [read post]
20 Jan 2024, 9:13 am by Friedman, Rodman & Frank, P.A.
In a recent case, the Third District Court of Appeals in Florida issued an opinion in an appeal involving a final summary judgment entered in favor of the defendants, appellees the University of Miami, Xue Zhong Liu, M.D. and Rebecca Rodriguez, L.P.N. [read post]
5 Jan 2024, 4:00 am
.# # #DECISIONMatter of Medical Professionals for Informed Consent, Individually & On Behalf of Its Members, Kristen Robillard, M.D., Zarina Hernandez-Schipplick, M.D., Margaret Florini, A.S.C.P., Olyesya Girich, Rt (r), & Elizabeth Storelli, R.N., Individually & On Behalf of Others Similarly Situated v Bassett [read post]
2 Jan 2024, 2:48 pm by Daily Record Staff
Polito, M.D., medical director of The Lung Center and chief of the Division of Pulmonary Medicine at Mercy, announced Tuesday. [read post]
1 Jan 2024, 8:10 pm by Kurt R. Karst
Shah, M.D., of Siyan Clinical Research in Santa Rosa, California, performed study-defined efficacy endpoints without being properly blinded as to blinded to certain safety assessments (“for example, clinical laboratory evaluations, vital signs, physical examinations, and adverse event assessments”). [read post]
27 Dec 2023, 1:15 pm by Tom Lamb
Heier, M.D., of Ophthalmic Consultant of Boston, and his colleagues stated: [Syfovre (pegcetacoplan)], the first treatment approved by the US Food and Drug Administration for geographic atrophy, slowed geographic atrophy lesion growth with an acceptable safety profile. [read post]